Overview
Junichi Shimizu practices practicing medicine in Nagoya, Japan.
Mr. Shimizu is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
He is actively involved in clinical research, co-authoring 71 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Junichi Shimizu
Is Junichi Shimizu a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Junichi Shimizu is classified as an Distinguished expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Junichi Shimizu participate in research or clinical trials?
Yes. Junichi Shimizu has published 71 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Junichi Shimizu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerMr. Shimizu isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Shimizu isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- EGFR Positive Lung CancerMr. Shimizu isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaMr. Shimizu isAdvanced. Learn about Lung Adenocarcinoma.
- Small Cell Lung Cancer (SCLC)Mr. Shimizu isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- Acute Interstitial PneumoniaMr. Shimizu isExperienced. Learn about Acute Interstitial Pneumonia.
- Idiopathic Pulmonary FibrosisMr. Shimizu isExperienced. Learn about Idiopathic Pulmonary Fibrosis.
- Interstitial Lung DiseaseMr. Shimizu isExperienced. Learn about Interstitial Lung Disease.
- Metastatic Brain TumorMr. Shimizu isExperienced. Learn about Metastatic Brain Tumor.
- Pancreatic Islet Cell TumorMr. Shimizu isExperienced. Learn about Pancreatic Islet Cell Tumor.
- ParonychiaMr. Shimizu isExperienced. Learn about Paronychia.
- Pleural EffusionMr. Shimizu isExperienced. Learn about Pleural Effusion.
- PneumoniaMr. Shimizu isExperienced. Learn about Pneumonia.
- Pulmonary FibrosisMr. Shimizu isExperienced. Learn about Pulmonary Fibrosis.
- Thymic Epithelial TumorMr. Shimizu isExperienced. Learn about Thymic Epithelial Tumor.